So long and thanks for all the science!

by Bob Lightowlers

Since its inception over 15 years ago, first under Monica Hughes, then Jeff Errington and more recently myself, ICaMB has continued to exceed expectations. There are many metrics to support this. For example, being invited to become a Fellow of the Royal Society, the oldest scientific academy in the world, is a remarkable honour and ICaMB was home to four of the five Fellows at Newcastle University. At the other end of the scale, our cohort of Early Career Researchers is truly remarkable, winning Henry Dale, University Royal Society and David Phillips Fellowships as well as BBSRC/MRC New Investigator and Career Development Awards.

Whilst the quality of research that was performed in ICaMB continues to be superb, it
is the working culture moulded by professional services, technical and academic members,
postdocs and students
that I really want to pay tribute to. I believe ICaMB has evolved an excellent and collegiate environment which most people have felt pleasure in being part of. It is with sadness that we say goodbye and many thanks to ICaMB, but with such exceptional members moving on to Newcastle University Biosciences Institute (NUBI) I have no doubt it will continue in spirit to punch well above its weight.

Essential metals for crystallographers: copper, gallium and a lot of gold

As the Newcastle Structural Biology lab, prepares to enter a new era with a fantastic state-of-the-art new in house X-ray system, we asked Rick to give everyone a perspective of the last 14 years of Protein Crystallography in Newcastle on behalf of all of us – Arnaud, Martin, Jane, Paula, Bert, Owen and Jon

by Prof Rick Lewis

A little over 20 years after von Laue, Friedrich and Knipping collected the first X-ray diffraction experiments on copper sulphate in 1912, Bernal and Hodgkin conducted the first macromolecular crystallography experiments – on pepsin, which was first crystallised by Northrop in 1928. These, and other early pioneers (including father-and-son Nobel laureates WH and WL Bragg), established the principles by which Kendrew and Perutz solved the first 3-D protein structures, myoglobin and haemoglobin, in 1958 and 1959.

If we fast-forward more than 40 years to the RAE2001, and a stated ambition for the immediate predecessor of ICaMB was to establish a protein crystallography group in Newcastle – I think it fair to say the the University was a little slow to recognise the value of structural biology!

Steven Hardwick was so excited at the lab’s opening in 2003 that he fell asleep

Nonetheless, the Director at the time, Monica Hughes, notably aided and abetted by Steve Yeaman, Jeremy Lakey, Bernard Connolly and Harry Gilbert, coerced the powers-that-be to dig behind the sofa for some loose change and, to cut a long story short, the Newcastle Structural Biology lab (NSBL) was born in 2003.



Rick preparing to shoot some crystals in the brand new kit back in 2004

Rick preparing to shoot some crystals in the brand new kit back in 2004

Back then, there were just two prime users of the X-ray diffractometer, my group and that of Mark Banfield (who left for the John Innes in 2008). Mark’s departure opened up an opportunity for Susan Firbank to establish her own research group, which in turn meant that Arnaud Baslé replaced Susan as the X-ray facility manager. In between Susan’s sudden departure in 2011 for a new life as a pharmacist, our colleagues in NICR, Martin Noble and Jane Endicott  were recruited to NICR. Paula Salgado arrived in 2012, Bert van den Berg and Owen Davies in 2013, and Jon Marles-Wright, whose beatific face used to light up the hoardings around the INTO building site, reappeared (after a sojourn up in Edinburgh) in Biology in 2016. In 6 years, the NSBL grew from a single PI to seven, plus Arnaud. The active user group now comprises well over 30 names.

In 2015, the University announced it had set up the Research Infrastructure Fund (RIF), a £31M pot of gold to which like-minded groups could apply for funds for new equipment and other essential infrastructure. To be honest, the RIF had passed under all our radars, and we were first alerted to it by a small molecule crystallographer in Chemistry. We put together what we thought was a strong case and were very pleased to hear just before Christmas 2015 that our bid was successful. Ironically, our colleague in Chemistry’s application to the same round was, ahem, unsuccessful, but a big hand to Mike for the heads-up!

Bye bye Miss Inverted Phi*: a proper farewell to the long serving old generator (*with apologies to Don Mclean)

So a year later, after a period of testing and comparing different options and going through a remarkably painless procurement procedure, we serenaded the final shut-down of the 13-year old X-ray equipment over a glass of prosecco. Bert and Martyna both won prizes for guessing closest how many operational hours (>95,000) the old generator had clocked up. The floor in the X-ray lab was relaid (humble apologies for the noise and the smell…) and we have just installed our brand new box-of-tricks.

So what do you get these days for a little under a million pounds? Not only a state-of-the-art X-ray detector, but a revolutionary new X-ray source. Instead of firing electrons at a rotating copper drum to generate X-rays, the new X-ray source relies upon the application of an electric current across a jet of liquid gallium, to produce an X-ray beam with the best spectral characteristics and intensity in the market place. Allegedly.

Almost ready to start shooting crystals!

Arnie, our new X-ray system, almost ready to start shooting those crystals!

Moreover, we have been early adopters of this brand new technology – in fact we are the first and currently only UK group with such an instrument! Exciting times indeed.

The upshot is a 100-fold improvement in performance. Data sets that would take an entire weekend to collect can now be done in 20 minutes, about what it would have taken to collect just a single image with the old system. The final piece of the jigsaw is expected in the late spring, when a sample changer will be installed. This robotic slave will allow us to load up 48 samples into a dewar of liquid nitrogen for the programmed sample changer to load one at a time onto the X-ray machine, take test exposures, rank sample quality, and then go back and collect full data sets on the best crystals. All of this without any user intervention. Amazing. If you’d told me back in 2003 that we would have this capability in-house before both Bernard and Harry had retired, I’d have laughed out loud….

Muhammad Ali, sepsis and antibiotic resistant superbugs

by Jeff Errington, in collaboration with Paula Salgado

I’m old enough to have watched in awe Muhammed Ali’s incredible exploits in the boxing ring, and his always entertaining and thought provoking, sometimes bizarre, TV interviews and clips. Most would agree that he was an amazing, inspirational human being.
Like many millions of people around the world, I was devastated to hear of his sudden passing. I watched a wonderful documentary on TV and read several articles about his amazing life on line. As a microbiologist, one seemingly throw away line caught my attention: cause of death, “septic shock”. I understood that he was frail, through the devastating effects of Parkinson’s disease. However, although I am not a clinical infectious disease specialist, to me, this suggests that Ali contracted an infection, almost certainly bacterial, which entered his blood stream. This is what “sepsis” means, and if untreated, a combination of the bacterial growth plus immune responses from the patient can lead to a catastrophic effect called “shock”, which can lead to multiple organ failure and death. In Muhammad Ali’s case, it seems a respiratory infection was the initial problem.

AMRIt is sadly not unusual for frail patients to contract serious infections in hospital. Clinicians are of course ready for this and would have responded by administering powerful antibiotics, hoping to kill the invading bacteria. Unfortunately, increasingly in the modern era, the bacteria causing these infections have become resistant to our better antibiotics. If the antibiotic administered turns out to be ineffective due to resistance, the patient can be rapidly overwhelmed, with fatal consequences.



by CDC, Centres for Disease Control and Prevention, USA

I have a personal interest in this scenario not only because I have devoted the last 20 years or so to trying to help discover and develop new antibiotics, but also because in 1994 my father died in hospital of multi-organ failure due to sepsis after a routine hip replacement.


by CDC, Centres for Disease Control and Prevention, USA

I don’t know whether Ali’s “septic shock” was due to an antibiotic resistant infection or whether his frail body couldn’t cope with yet another infection. But if antibiotic resistant bacteria were the cause of his death, wouldn’t it be amazing if the publicity and outpouring of grief associated with his passing could trigger a transformational change in our collective resolve to find urgently needed solutions to the impending antibiotic resistance catastrophe. One final positive postscript to his enduring legacy.



Antimicrobial review

Wellcome Trust Antibiotic Awareness Week

Happy 60th birthday, Jeff!

by Prof Jeff Errington

Daunting 60?

IMG_4117I turned 60 on the 3rd of May. The year leading up to that was traumatic for me because, psychologically, it felt like a turning point in life – a long and enjoyable career behind me but a rapidly foreshortening window ahead! Surprisingly, things suddenly looked up when the birthday actually arrived (last Tuesday) – I didn’t really feel any different!

Jeff welcomes everyone as an audience of friends and colleagues gathered for celebrations

Jeff welcomes everyone as an audience of friends and colleagues gathered for celebrations

And then I had a really exciting science symposium and lab reunion to look forward to, which took place on Friday (mostly science) and Saturday (mostly fun!).


So many wanted to come!

davidquote2We wondered how many of the past members of the lab would be able to make it, given that they were scattered to the four corners of the earth and we had no funds to cover their expenses. To my astonishment and delight, over 20 lab alumni agreed to come, and we were able to fill all of the 16 speaker slots with alumni from outside Newcastle.

Alumni came from far and wide to join the celebrations.

Alumni came from far and wide to join the celebrations.

The speakers came from 4 different continents, and though most were high powered talks on bacterial cell biology, other topics extended through yeast and worms to bat wing development!


Meriem El Karoui explaining the mathematical model used in her work on DNA repair

Meriem El Karoui explaining the mathematical model
used in her work on DNA repair


Nicola explains how her group collects bats for their developmental biology research.

Bat collection methods by Nicola

ianA day of great science – and warm friendship

Fun trip down memory lane

Fun trip down memory lane


I was overwhelmed by the experience: seeing so many old friends again, the fantastic quality and quantity of science, and the showering of gifts and kind words.




"Looking back at the pictures from my time in Newcastle, it seems we were always doing fun stuff together, something really only possible because Jeff is such a great guy!" Jan-Willem

“Looking back at the pictures from my time in Newcastle, it seems we were always doing fun stuff together, something really only possible because Jeff is such a great guy!” Jan-Willem

I was of course obliged to attempt some profound words at the closing. What struck me was that I could not work out what it was that I had done which had resulted in such an amazing scientific legacy.

philippeThe only thing that I can think of is that if you can once assemble a critical mass of good scientists, which includes a few very good people, the culture or ecology of the lab becomes self sustaining. New people coming into the lab are well trained and inspired by the existing members, and they in turn go on to succeed in their own right. My job mainly becomes one of trying to make sure that the environment and infrastructure of the lab is capable of enabling good scientists to achieve their potential.




We all agreed that it had been a great idea to get everyone back together again and we plan to have another reunion (outside of any special birthday) again in a few years’ time.

Happy birthday, Jeff!

Happy birthday, Jeff!

Congratulations, Prof Gilbert, FRS!

by Prof. Harry Gilbert, FRS, FMedSci

I was asked to write a blog about my election as a Fellow of the Royal Society. I start by apologising for my ineptitude compared to the “professional” social media people in the Institute. So, what to say? Well, maybe the process might be of interest.

How do you get elected as an FRS?

ICaMB's FRS: Prof Jeff Errington and Prof Harry Gilbert

ICaMB’s FRS: Prof Jeff Errington and Prof Harry Gilbert

You need to be proposed and seconded by current FRS’s. Jeff tried twice to propose me before I went to the USA and a third time (September 2012) upon my return, at which point I said OK. I had to generate a full CV, list 20 papers and include PDF versions of these articles, and the proposers were required to write a three page narrative on my research.

Every year material is updated. The first year I wondered what feedback I might get but I soon realized that no one says anything to you. I rapidly put the issue to one side and did not give it any thought.


‘Wrong Direction’ – Prof Gilbert forms a karaoke boyband with other eminent scientists at a conference in Japan


Looking back on my research it’s evident that most of my science was done with collaborators who are much smarter than me. So, I consider myself to be extremely fortunate to have worked with these people.



The talented people currently working in the Gilbert/Bolam labs

The talented people currently working in the Gilbert/Bolam labs


Finally, the election

In late March of this year, I received a letter from the Royal Society marked “In strictest confidence“. I assumed it was yet another reference for someone applying for a grant to the Royal Society and I thought “another job to do”. I read the letter several times and the words “you are on the list of candidates submitted to become an FRS” was hard to digest. When it said you needed 2/3 of the votes to be elected, I became dubious about my chances. On speaking to Jeff, he explained that only one person in the last 150 years has failed to become an FRS at this stage. I was thus confident that not even I could screw this up.

Fun celebrations!

Fun celebrations!

However, keeping it secret for a month before the election took place was extremely hard as I don’t do secrets. I did, however, tell Rosie, my wife, who initially shared my excitement of the news. Her enthusiasm waned somewhat as I kept on about it at home for a day or two. At this point, Rosie said “I hope you don’t become too grand” which ceased any talk about the FRS. I am pleased to say that Rosie’s excitement was rekindled when she realised that she will likely get the opportunity to meet Brian Cox (who also became an FRS this year) who she rates as “very dishy, particularly for a scientist”.


How does it feel to be an FRS?

What are my thoughts about being an FRS? Well, shocked but also excited, although I feel a complete fraud.

Prof Gilbert's speech to his colleagues at ICaMB

Prof Gilbert’s speech to his colleagues at ICaMB

I was very pleased that so many people were able to come and celebrate with me on Friday, I would like to thank you all for coming. I also hope that people will think that “if Harry can become an FRS then the bar is not so high”, and that this will result in other people becoming Fellows in the next few years. In 30 years at Newcastle, I have never worked in a place with so many talented people, and it is clear that ICaMB merits more than two Fellows of the Royal Society.


Spending Review 2015 – what does it mean for science?

by Paula Salgado

After many months of speculation and concern, the details of the Spending Review 2015 when it comes to science feels, at first, as a massive relief. After all, the Chancellor announced that science funding would be protected in real terms this time, “raised to £4.7bn by 2020 and capital spending to remain at 6.9£bn over this period”. We should be celebrating, surely! However, a detailed analysis shows that this really means that public investment in science will be frozen for the next 5 years. In fact, according to a detailed analysis (source:

  • The Science Budget is and will remain lower in real terms than it was in 2010.
  • The Science Budget is falling per person living in the UK, and as a fraction of GDP. By 2020, the Science Budget will be nearly 20% lower as a fraction of GDP than it was in 2010.

And we also need to look at the details, not just the main headlines. The science resource budget (those £4.7bn) will now include a newly announced Global Challenges Fund “to ensure UK science takes the lead in addressing the problems faced by developing countries whilst developing our ability to deliver cutting-edge research.” Depending on how this fund will be managed and organised, there is a concern that this could mean that some of the funds which are currently part of the Science Budget will be diverted to sustain the Governments commitment to spend 0.7% of GDP on international development.

It is also still not clear how the implementation of the Nurse Review in to how Science is funded in the UK will undoubtedly affect the funding landscape. Setting up an overarching structure will have its costs and we need to see how that will translate into funding allocation.

But most importantly, this flat cash real-terms freeze is yet another failed opportunity to increase investment in research and development that is required to maintain the UK’s leading role and sustain economic growth. Five years of flat cash has already had a detrimental effect on R&D, not only in terms of the decline in available funds but also in reputation and work of labs across the country. With the positive economic signs announced by the Chancellor, the Government had a chance to reverse the current managed decline of R&D in the UK but decided to continue on a similar path. The long term effects of these decisions will only be clear over the next few decades – but that is why many, including the Wellcome Trust and RCUK, reacted with caution at the real-term freeze announcement.

The lead up to the Spending Review

Lettter in FT calling on the Chancellor not to cut science funding (Sept 7, 2015)

Lettter in FT calling on the Chancellor not to cut science funding (Sept 7, 2015)

With rumours of 20 to 40% cuts being “leaked” throughout the summer and even a rushed review from a private consulting company looking on how to make cost savings across the Department for Business, Innovation & Skills (BIS), the scientific community had reasons to be concerned. Many voices spoke publicly against the axe falling on public science funding: a letter from many charities and learned societies, together with several companies was published in the Financial Times, UK top scientists sharing their views on Buzzfeed and several opinion pieces in the media from leading scientists and journalists urged the Government to not impose any cuts and seriously consider increasing current investment in order to support future growth. Behind the scenes, influential learned societies and campaign groups lobbied the Chancellor, the new Minister for Universities and Science, Jo Johnson, and the new Secretary for BIS, Sajid Javid to stress the same points. And the House of Commons Science & Technology Committee made detailed recommendations that the science budget should be increased, just a few weeks before the Spending Review announcement.

Science is Vital chair, Dr Jenny Rohhn,  and  vice-chair, Prof Stephen Curry, at the rally in London, 26th October 2015

Science is Vital chair, Dr Jenny Rohhn, and vice-chair, Prof Stephen Curry, at the rally in London, 26th October 2015

But it wasn’t just prominent voices. As in 2010, Science is Vital organised a grass roots campaign to get the voice of scientific community and all supporters of science be heard. There was a big science event in London with scientists, patient groups, journalists and entertainers all rallying to support sustained public investment in science. Across the UK, local events raised the same issues within local communities, getting people to joint watch the event in London but also discuss how science is important to them. And nearly 2000 people wrote a postcard to George Osborne, telling him why they thought Science is Vital.

Science Minister commenting on Science Budget announcement in Spending Review 2015 on Tweeter

Science Minister commenting on Science Budget announcement in Spending Review 2015 on Tweeter

The fact that the Science Minister has now used the phrase “Science is Vital” publicly in at least two occasions, including in his reaction to the SR2015 on social media, means that this important message is getting across our politicians and key decision makers. As more  details of the Spending Review are announced in the coming days and weeks, we will surely have opportunities to continue to let them know why Science is Vital.

What do you think? You can leave your comments below.
Science is Vital is also asking for your reactions.





PhD studentships for 2015 – now recruiting!

As final year undergraduate students up and down the country approach the end of their degrees, it’s decision time. For many, postgraduate studies are the chosen route in the topic that has excited them the most during the their undergraduate studies. If you, or a friend/colleague, are one of those that find Cell and Molecular Biosciences the main topic of interest, this post is for you.

A view of Newcastle, taken during ICaMB's annual boat trip - you could join us next year!

A view of Newcastle, taken during ICaMB’s annual boat trip – you could join us next year!

Would you like to do your PhD in one of the top UK Research Institute for Biological Sciences?  In a city that has just been voted as the best city in the UK? Then one of the PhD studentships currently available at ICaMB could be what you are looking for!

As an ICaMB PhD student, you will benefit from being in a dynamic and well funded research environment with access to state of the art technology.  You would be working amongst leading experts in several fields from bacterial cell biology all the way through to eukaryotic cell signalling and cancer research.


We all know that a PhD is not only about your research, so you will also be part of a thriving community of postgraduate students, with many events, both social, scientific and career oriented, organised by ICaMB’s PhD student association PAN!C.  You can read more about PAN!C in a previous ICaMB blogpost.

Here we list MRes/PhD Studentships scheduled to begin in ICaMB in September 2015.  These are also listed on the ICaMB website, where you can also find further details and guidelines on how to apply.  However, if you would like further details about the projects, you can contact the named supervisor directly or the ICaMB Postgraduate Tutor Dr Tim Cheek (email In addition, the Institute expects to kick start the careers of several new academic recruits by offering associated postgraduate studentships in the new academic year, September/October 2015. These posts will be advertised before the end of February 2015. If you are potentially interested or would like more details at this stage, please contact Professor Bob Lightowlers, Director of ICaMB. (

Newly added:
Title: Investigating the nanoscale structure and function of the bacterial cell division machinery
Sponsor: Newcastle University
Supervisor(s): Dr Seamus Holden, Prof. Jeff Errington
Contact for further details: Dr Seamus Holden (
Interested in combining bacterial cell biology with cutting-edge super-resolution microscopy techniques to figure out how bacteria divide?
The structure and dynamics of the bacterial cell division machinery remain mysterious, because this machinery is spatially organized on the nanometre scale, below the resolution of conventional light microscopy. The studentship will focus on using single molecule super-resolution microscopy to study bacterial cell division in living cells, in order to elucidate the physical mechanisms of cytokinesis. Cross-disciplinary training will be provided in advanced microscopy, biophysics, molecular biology and microbiology.
Deadline: This position will be advertised shortly. In the meantime, please contact Dr Seamus Holden for further information.



Title: MRes/PhD Studentship in the Institute for Cell and Molecular Biosciences – Ebola Virus Vaccine: Development of a Salmonella-Based Vaccine Delivery Platform – Ref CB113
Sponsor: Barbour Foundation
Supervisor(s): Dr Anjam Khan (Newcastle), Dr Pietro Mastroeni (Cambridge University) and Dr Gary Kobinger (Manitoba University, Canada)
Contact for further details: Dr Anjam Khan
Interested in contributing towards the development of a novel Ebola virus vaccine?  Ebola is a highly virulent virus causing severe haemorrhagic fever with a high fatality rate in humans. This PhD project will explore the application of Salmonella as a novel oral vaccine delivery system for Ebola.  The studentship will involve designing and constructing new vectors to optimize the expression and immunogenicity of recombinant Ebola antigens.
Cross-disciplinary training will be provided in molecular biology, microbiology, biotechnology, infection, and immunity.  Training will also be provided in the collaborators laboratories in Cambridge.
Further Information

Title: STFC Funded PhD Studentship in Biophysical Chemistry – Creating realistic models of bacterial outer membranes for antimicrobial research and diagnostic assay development – Ref CB114
Sponsor: Science Technology and Facilities Council (STFC) & OJ-Bio Ltd
Supervisor(s): Prof Jeremy Lakey, Dr L Clifton & Dr V Lawson
Contact for further details: Prof J Lakey
This studentship builds up on recent successes in the Lakey research group developing accurate models of the outer membrane of Gram negative bacteria. These will enable more efficient research in antimicrobials and diagnostics. The successful applicant will demonstrate enthusiasm for this cross disciplinary area of research and any science degree including biochemistry, chemistry, physics etc. is suitable. The project involves a collaboration between Newcastle University, the Rutherford Appleton laboratory and OJ Bio, a young diagnostics company. The student will spend time at the neutron source at the Rutherford Appleton laboratory at Harwell.
Further Information
Deadline: The position will remain available until suitable candidates are appointed. Early application is advised.

Title: Sporulation in the human pathogen Clostridium difficile: structural and functional studies – Ref CB115
Sponsor: Medical Research Council (MRC)
Supervisor(s): Dr Paula Salgado and Prof Waldemar Vollmer
Contact for further details: Dr P Salgado
Are you a keen, motivated student, with an interest in microbiology and/or structural biology and an inquisitive, curious approach to research? Interested in bacterial pathogens, antibiotic resistance and in bacteria causing hospital acquired infections? The student will benefit from exceptional training in diverse disciplines: molecular and cell biology, protein purification, structure determination and PG biology to provide new understanding into Cdiff sporulation that would open new therapeutic avenues.
Further Information
Deadline: The position will remain available until suitable candidates are appointed. Early application is advised.


Eukaryotic cell biology and ageing

Title: The impact of a senescent-like phenotype in post-mitotic cells and its impact on ageing – Ref CB116
Sponsor: Medical Research Council (MRC)
Supervisor(s): Dr J Passos, Prof D Young & Dr N LeBrasseur
Contact for further details: Dr J Passos
This project aims to understand mechanisms of ageing using mice models, particularly the role of telomeres and mitochondria  and inflammation in the process. It involves a rotation in the Robert and Arlene Kogod Center on Aging, Mayo Clinic (US).
Further Information
Deadline: 28th February

Title: Role of mitochondrial Reactive Oxygen Species in Parkinson’s disease – Ref CB117
Sponsor: Medical Research Council (MRC)
Supervisor(s): Dr A Sanz, Dr A Reeve, Dr V Korolchuk & Prof D Turnbull
Contact for further details: Dr Alberto Sanz
The project aims to better understand the causes of Parkinson’s disease creating new Drosophila melanogaster models and using mammalian cell cultures.

Further Information 

Deadline: The positions will remain available until suitable candidates are appointed.  Early application is advised.



One new aspect of the PhD studentships on offers this year is a renewed partnership with the Universities of Durham and Liverpool, with which we have a joint BBSRC Doctoral Training Partnership. This is a strategic partnership in Biosciences doctoral training between three research-intensive universities in these three northern cities of great industrial heritage.

The Partnership is offering up to 16 four-year fully funded studentships starting in October 2015. A wide range of 28 projects across the Partnership are available for application under the broad themes of Agriculture & Food Security, Bioscience for Health and World Class Bioscience.

As the leading institute in Newcastle carrying out BBSRC-funded research, many of the projects on offer in Newcastle will be based in ICaMB.  Please note that these research projects are in competition for funding with one another. There are two stages to the selection process and usually the projects which receive the best applicants will be awarded the funding.

Projects available at ICaMB, deadline 28th February

Title: Investigating the essential role of copper in biotechnologically important bacteria
Sponsor: BBSRC DTP
Supervisor(s): Prof C Dennison, Prof J C Murrell & Dr K Waldron
Contact for further details:
 Prof C Dennison
Further Information

Title: Communication across the membrane during bacterial cell division
Sponsor: BBSRC DTP
Supervisor(s): Prof R Lewis & Prof W Vollmer
Contact for further details: Prof R Lewis
Further Information

Title: Role of telomere-driven senescence in age-dependent muscle decline
Sponsor: BBSRC DTP
Supervisor(s): Dr J Passos, Dr Aphrodite Vasilaki & Dr Nathan LeBrasseur
Contact for further details: Dr J Passos
Further Information

Title: Interventions that affect fitness of cells and animals with dysfunctional telomeres
Sponsor: BBSRC DTP
Supervisor(s): Prof D Lydall, Dr N Kenneth, Prof A Morgan & Prof C Price
Contact for further details: Prof D Lydall
Further Information

Title: Fungal-specific RNA endonucleases: novel targets for anti-fungal agents
Sponsor: BBSRC DTP
Supervisor(s): Dr C Schneider, Prof M Caddick & Prof J Quinn
Contact for further details: Dr C Schneider
Further Information

Title: The impact of novel chromatin regulators on genome stability
Sponsor: BBSRC DTP
Supervisor(s): Dr L Maringele & Dr S Grellscheid
Contact for further details: Dr L Maringele
Further Information

Title: The identification of key virulence factors involved in the host-bacterial interaction of Salmonella typhimurium ST313
Sponsor: BBSRC DTP
Supervisor(s): Dr P Aldridge & Prof J Hinton
Contact for further details: Prof P Aldridge
Further Information

Title: Virulence factors of human and bird Trichomonad parasites targeting host proteoglycans: integrating evolutionary biology, comparative genomics, biochemistry and cell biology
Sponsor: BBSRC DTP
Supervisor(s): Prof R Hirt, Dr D Bolam & Prof N Hall
Contact for further details: Prof R Hirt
Further Information

Title: Re-engineering the metabolism of the bacterium Bacillus subtilis for the synthesis Mycosporine-like amino acids
Sponsor: BBSRC DTP
Supervisor(s): Professor C Harwood (Newcastle), Dr Malcolm Horsburgh (Liverpool), Dr Douglas Cossar (Croda Europe)
Contact for further details: Professor C Harwood
Further Information

Title: Ammonium sensing in the wheat pathogen Zymoseptoria tritici
Sponsor: BBSRC DTP
Supervisor(s): Dr J Rutherford, Prof B van den Berg and Dr A Sadanandom
Contact for further details: Dr J Rutherford
Further Information